SG/CALL/SARTORIUS STEDIM BIO/335/0.025/21.06.24 Stock

Warrant

47D7S

DE000SW1J630

Real-time Euronext Paris 12:30:00 2024-04-23 EDT
0.0105 EUR -.--% Intraday chart for SG/CALL/SARTORIUS STEDIM BIO/335/0.025/21.06.24
1 month-95.23%
3 months-90.87%

Static data

Product typeWarrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer Société Générale Société Générale
47D7S
ISINDE000SW1J630
Date issued 2023-07-27
Strike 335
Maturity 2024-06-21 (39 Days)
Parity 40 : 1
Emission price 0.69
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.795
Lowest since issue 0.0105
Delta0.03x
Omega 12.74
Premium59.65x
Gearing500.24x
Moneyness 0.6272
Difference Strike 127.3
Difference Strike %+38.00%
Spread 0.019
Spread %95.00%
Theoretical value 0.0105
Implied Volatility 55.98 %
Total Loss Probability 98.52 %
Intrinsic value 0.000000
Present value 0.0105
Break even 335.42 €
Theta-0x
Vega0x
Rho0x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
203.6 EUR
Average target price
251.3 EUR
Spread / Average Target
+23.44%
Consensus
  1. Stock Market
  2. Warrants
  3. 47D7S Warrant
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW